19 completed, 5 unknown, 2 withdrawn, 1 recruiting. 28 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 28 | Completed 19, Unknown 5, Withdrawn 2, Recruiting 1, Terminated 1 |
Follow Hyperphosphatemia: new trials by email Literature Review of Hyperphosphatemia trials Research Report on Hyperphosphatemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phosphate Diet Strategies to Lower Blood Phosphate in Dialysis Patients diet education - Hyperphosphataemia, Phosphorus | Not applicable | Completed | Kufa University | 200 | 2024-10-01 | 2025-09-18 |
| Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis multimedia education - End-Stage Kidney Disease, Hyperphosphatemia | Not applicable | Completed | Liu, Liu-Yin | 43 | 2023-07-04 | 2024-05-17 |
| mHealth for Phosphorus Management in CKD. mHealth App - Dialysis Related Complication | Not applicable | Unknown | Hospital Universitari de Bellvitge | 50 | 2022-06-01 | 2023-09-22 |
| Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease Intervention group; NNRD group - Chronic Kidney Disease(CKD), Hyperphosphatemia | Not applicable | Completed | Bo Feldt-Rasmussen | 60 | 2020-11-30 | 2024-04-12 |
| Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE) Liberal phosphate target, Intensive phosphate target - Kidney Failure, Chronic, Hyperphosphatemia | Not applicable | Recruiting | The University of Queensland | 3600 | 2019-12-10 | 2026-08-26 |
| Effectiveness of The Phosphate Mobile App on Serum Phosphorus in Adult Hemodialysis Patients With Hyperphosphatemia Phosphate mobile app, One-off dietary counselling with a phosphate booklet - Hyperphosphatemia, End Stage Renal Disease on Dialysis | Not applicable | Completed | Taylor's University | 74 | 2019-11-01 | 2021-03-10 |
| Phosphate Microvascular Study Withholding standard phosphate binder - End Stage Renal Disease, Hyperphosphatemia | Not applicable | Unknown | Veterans Medical Research Foundation | 20 | 2019-01-01 | 2018-08-24 |
| Behavioral Management of Phosphorus in Hemodialysis Patients Education (Edu), SM intervention, Social Cognitive Therapy (SCT) - Cardiovascular Disease (CKD), Hyperphosphatemia | Not applicable | Completed | NYU Langone Health | 40 | 2018-04-23 | 2018-05-31 |
| Low-Phosphate Diet and Fibroblast Growth Factor-23 Level Low-phosphate diet - Chronic Kidney Disease Requiring Chronic Dialysis, Hyperphosphatemia | Not applicable | Completed | Wan-Chuan Tsai | 35 | 2018-01-03 | 2018-10-02 |
| Egg White for Phosphorus Control in Haemodialysis Patients Egg White replacement - Renal Insufficiency, Chronic, Dialysis | Not applicable | Unknown | Federico II University | 20 | 2017-06-15 | 2017-09-15 |
| Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices Current Low Phosphorus Diet Prescription, Modified Low Phosphorus Diet Prescription - Renal Dialysis, Hyperphosphatemia | Not applicable | Completed | University College Cork | 74 | 2017-03-06 | 2020-01-18 |
| Dietary Phosphorus Load and Postprandial Serum Phosphate in HD Patients Standard Diet, Modified Diet - Hemodialysis | Not applicable | Completed | University College Cork | 8 | 2016-11-26 | 2021-04-30 |
| Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients enhanced individualised therapy, non-enhanced individualised therapy, regular intervention - Hyperphosphatemia, End-stage Renal Disease | Not applicable | Completed | Huashan Hospital | 72 | 2016-01-01 | 2018-02-26 |
| Educational Programme Impact on Serum Phosphate Control Educational Programme - Renal Insufficiency, Chronic | Not applicable | Completed | University of Sao Paulo | 180 | 2015-11-01 | 2017-02-20 |
| Efficacy of Dietary Education and Education on Phosphate Binder Use in Hemodialysis Patients Dietary education, Education on phosphate binder use - Hyperphosphatemia, End-stage Renal Disease | Not applicable | Completed | Ajou University School of Medicine | 70 | 2015-07-01 | 2016-04-29 |
| Fosrenol and Phosphorus Balance - Lanthanum Carbonate lanthanum carbonate - Chronic Kidney Failure, End-stage Renal Disease | Not applicable | Completed | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 9 | 2012-03-01 | 2017-05-09 |
| Effect of Restriction of Foods Containing Phosphorus Additives Restriction on food containing phosphorus additives, Standard care - End-stage Renal Disease, Hyperphosphatemia | Not applicable | Completed | Faculdade de Ciências Médicas da Santa Casa de São Paulo | 140 | 2012-01-01 | 2015-03-10 |
| Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate Calcium acetate, Sevelamer - Haemodialyzed Patients, Hyperphosphatemia | Not applicable | Withdrawn | Romanian Society of Nephrology | 2012-01-01 | 2017-12-22 | |
| PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum K2CG chewing gum - Hyperphosphatemia, Chronic Kidney Disease | Not applicable | Completed | Denver Nephrologists, P.C. | 36 | 2011-07-01 | 2011-11-15 |
| The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan Sevelamer Carbonate (Renvela) - Dialysis, Cardiovascular Disease | Not applicable | Terminated | Brigham and Women's Hospital | 24 | 2011-06-10 | 2017-07-31 |
Showing 20 of 28. Sign in to see all of them.
Kidney Failure, Chronic (10) · Renal Insufficiency, Chronic (6) · Cardiovascular Diseases (2) · Atherosclerosis (1) · Bone Diseases, Metabolic (1) · Glucose Intolerance (1) · Hyperkalemia (1) · Hypoalbuminemia (1) · Inflammation (1) · Insulin Resistance (1) · Malnutrition (1)
Metabolic Diseases (28) · Nutritional and Metabolic Diseases (28) · Phosphorus Metabolism Disorders (28) · Pathologic Processes (16) · Pathological Conditions, Signs and Symptoms (16) · Chronic Disease (15) · Disease Attributes (15) · Female Urogenital Diseases (15) · Female Urogenital Diseases and Pregnancy Complications (15) · Kidney Diseases (15) · Male Urogenital Diseases (15) · Renal Insufficiency (15) · Urogenital Diseases (15) · Urologic Diseases (15) · Renal Insufficiency, Chronic (9)
Educational Status (3) · Nutrition Assessment (3) · Sevelamer (3) · lanthanum carbonate (2) · Calcium Carbonate (1) · Standard of Care (1) · Sugars (1) · calcium acetate (1)
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (2) · University College Cork (2) · Ajou University School of Medicine (1) · Bo Feldt-Rasmussen (1) · Brigham and Women's Hospital (1) · Denver Nephrologists, P.C. (1) · Endeavor Health (1) · Faculdade de Ciências Médicas da Santa Casa de São Paulo (1) · Federico II University (1) · Fresenius Medical Care North America (1) · Hospital Universitari de Bellvitge (1) · Huashan Hospital (1) · Karolinska Institutet (1) · Kufa University (1) · Liu, Liu-Yin (1)
United States (6) · Brazil (3) · Taiwan (3) · Canada (2) · China (2) · Australia (1) · Denmark (1) · France (1) · Iraq (1) · Ireland (1) · Israel (1) · Italy (1) · Malaysia (1) · New Zealand (1) · Romania (1)
Joseph Eustace, MB (2) · Adrian Covic, Prof (1) · Anders Alvestrand, MD PhD (1) · Ashwini Sehgal, MD (1) · Bo Feldt-Rasmussen, Professor (1) · Gabriel Mircescu, Prof (1) · Geoffrey A Block, MD (1) · Jiaqi Qian, MD (1) · Joel D. Kopple, M.D. (1) · Jonas Axelsson, MD, PhD (1) · Jong Cheol Jeong, MD (1) · Kambiz Zandi-Nejad, MD (1) · Kamyar Kalantar-Zadeh, MD, MPH, PhD (1) · Margareth LL Fornasari, RD (1)
PMID 40576086, PMID 19211470, PMID 19539185, PMID 23797006, PMID 26843138, PMID 27528215, PMID 28398983, PMID 29064141, PMID 30459073, PMID 31302884, PMID 32706698, PMID 34462278, PMID 35187396, PMID 36472416, PMID 37598748, PMID 39671553, PMID 40238244, PMID 40241437, PMID 40638247, PMID 41033875